Search for: "In re NTP, Inc." Results 1 - 20 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2011, 2:24 pm by Lawrence B. Ebert
” In re Baker Hughes, Inc., 215 F.3d 1297, 1301 (Fed. [read post]
12 Jul 2010, 3:10 am by Scott A. McKeown
Cir. 2007); and In re Translogic Technology, Inc., 504 F.3d 1249, 84 USPQ2d 1929 (Fed. [read post]
2 Apr 2013, 1:27 pm by Lawrence B. Ebert
from Ex parte DAMSOHN It is fundamental patent law that “each and every claim limitationmust be explicitly or inherently disclosed in the prior art” for an anticipationrejection to be proper.In re NTP, Inc., 654 F.3d 1279, 1302(Fed. [read post]
29 Dec 2010, 3:10 am by Scott A. McKeown
Oral arguments have been scheduled for In re Tanaka (January 10), In re NTP (February 10), and In re Mostafazadeh (February 11). [read post]
19 Apr 2016, 12:03 pm by Lawrence B. Ebert
” In re NTP, Inc., 654 F.3d 1279, 1288(Fed. [read post]
8 May 2012, 6:31 pm by Lawrence B. Ebert
In re NTP, Inc., 654 F.3d 1268, 1274 (Fed. [read post]
17 Jun 2016, 3:05 pm by Lawrence B. Ebert
See In re NTP, Inc., 654 F.3d 1279, 1292 (Fed. [read post]
1 Nov 2018, 9:55 am by Dennis Crouch
The Jazz Pharm. court did not explain its reasoning for this statement but merely cited In re NTP, Inc., 654 F.3d 1279 (Fed. [read post]
14 Jul 2008, 9:17 am
RIM appeared:see also NTP, Inc. v. [read post]
2 Mar 2008, 3:40 am
The Eolas patent, unlike the NTP patents, got through re-examination without any amendment. [read post]
13 Sep 2018, 10:27 am by Lawrence B. Ebert
The underlying factualfindings include whether a reference was publicly accessible.In re NTP, Inc., 654 F.3d 1279, 1296 (Fed. [read post]